Objective-The vascular competence of human-derived hematopoietic progenitors for postnatal vascularization is still poorly characterized. It is unclear whether, in the absence of ischemia, hematopoietic progenitors participate in neovascularization and whether they play a role in new blood vessel formation by incorporating into developing vessels or by a paracrine action. Methods and Results-In the present study, human cord blood-derived CD34 ϩ (hCD34 ϩ ) cells were transplanted into preand postgastrulation zebrafish embryos and in an adult vascular regeneration model induced by caudal fin amputation. When injected before gastrulation, hCD34 ϩ cells cosegregated with the presumptive zebrafish hemangioblasts, characterized by Scl and Gata2 expression, in the anterior and posterior lateral mesoderm and were involved in early development of the embryonic vasculature. These morphogenetic events occurred without apparent lineage reprogramming, as shown by CD45 expression. When transplanted postgastrulation, hCD34 ϩ cells were recruited into developing vessels, where they exhibited a potent paracrine proangiogenic action. Finally, hCD34 ϩ cells rescued vascular defects induced by Vegf-c in vivo targeting and enhanced vascular repair in the zebrafish fin amputation model.
I t has long been supposed that cells present in the bone marrow, peripheral blood (PB), and cord blood (CB), which copurify with hematopoietic stem cells (HSCs), also give rise to endothelial cells. This speculation was supported by the notion that CD34 ϩ and CD133 ϩ cells differentiate, in culture and in vivo, into cells that express mature endothelial cell markers. These cells, called endothelial progenitor cells (EPCs), [1] [2] [3] have been the subject of numerous basic and translational studies showing their participation in neovascularization. Recent studies have revealed possible separation between hematopoietic-and nonhematopoietic-derived EPCs. 4 -8 These 2 cell types have been called early and late EPCs, 9 or colony-forming unit-endothelial cells (CFU-ECs) and endothelial colony-forming cells (ECFCs). 7 They are fundamentally distinguished on the basis of hematopoietic marker expression (eg, CD45) and the ability to proliferate or to differentiate into endothelial cells. 10 Separation between hematopoietic and the endothelial lineages during early mouse 11 and zebrafish 12 development is established during by asymmetrical division of primitive cells located in the dorsal aorta endothelium, through a novel differentiation event called endothelial-hematopoietic transition (EHT). [13] [14] [15] [16] More uncertain is whether cells with a similar potency of generating HSCs or endothelial cells are present at postnatal stages 17 ; recently, however, derivation of endothelial cells from CD34 ϩ /CD38 ϩ /CD45 ϩ /CD133 ϩ CB progenitors was demonstrated, 18 suggesting the existence of similar progenitors at least during fetal life.
The zebrafish (Danio rerio) embryo provides several advantages for in vivo study of vascular morphogenesis, based on the opportunity to observe in real time the development of embryonic blood vessels 19, 20 and also on the remarkable conservation of molecular pathways regulating vascular development in mammals, such as those regulated by endothelial (eg, Flk-1) or hematopoietic (eg, Scl, Runx1) master genes. [21] [22] [23] The objective of the present work was to explore the developmental potency and the vascular competence of human CB CD34 ϩ cells, exploiting the flexibility offered by zebrafish system.
Materials and Methods
An expanded supplemental version of the Methods section is available online at http://atvb.ahajournals.org.
Ethical Statement
Collection of CB samples was performed with written consent on a voluntary basis and after approval by institutional review boards. Authorization numbers are provided in the supplemental material.
Fish Maintenance
Breeding zebrafish, wild-type AB strain, transgenic (Tg) strain Tg(KDRI:enhanced green fluorescent protein [EGFP]) S843 (ZIRC, University of Oregon), and the Tg(fli1:EGFP) y1 line (from the laboratory of Nathan Lawson, University of Massachusetts Medical School) were maintained at 28°C on a 14-hour light/10-hour dark cycle, according to established procedures.
hCD34 ؉ and hCD14 ؊ Cell Selection and Characterization
Isolation of human CB-derived CD34 ϩ (hCD34 ϩ ) and CD14 Ϫ cells was performed by using magnetic selection with a MINI-MACS system after separation of CB and PB mononuclear cells onto density gradients. hCD34 ϩ cell purity (87.4Ϯ2.9%; nϭ9) was assessed by flow cytometry in preliminary experiments. Before injection, cells were labeled using Orange Cell Tracker (Molecular Probes, Invitrogen) according to the manufacturer's instruction.
Cell Transplantation Assays and Morpholino RNA Injection
Blastula stage or tricaine (0.04 mg/mL, Sigma) anesthetized 48 hours post fertilization (hpf) stage AB or Tg(fli1:EGFP) y1 zebrafish strains embryos were injected with Orange Cell Tracker-labeled CD34 ϩ , CD14 Ϫ cells (4 nL injection volume, 500 to 1000 cells/embryo), or Vegf-c morpholino (MO) RNA.
Embryo Sectioning and Confocal Microscopy
For tissue sectioning, CD34 ϩ cell-injected embryos were fixed with 4% paraformaldehyde, embedded in cryostat mounting medium (Killik, Bioptica), and transversally cut (8 m) at different sectioning planes in the regions of the head and the dorsal artery/dorsal aorta locations for immunofluorescence.
Whole-Mount Alkaline Phosphatase Staining, Immunodetection Assays, and In Situ Hybridization
Zebrafish control and cell-injected embryos were fixed at the indicated time points using 4% paraformaldehyde for 2 hours at room temperature, after which they were processed for in situ hybridization, alkaline phosphatase staining, terminal deoxynucleotidyl transferase dUTP nick-end labeling, or phosphohistone H3 whole-mount immunofluorescence.
Statistical Analysis
Statistical analysis was performed by unpaired t test or 1-way ANOVA with Newman-Keuls post hoc analysis using Prism GraphPad statistical software; each experiment was carried out in at least in triplicate. Data are indicated as meanϮSE.
Results

Fate of hCD34 ؉ Progenitors Transplanted Into the Developing Zebrafish Blastula
Orange Cell Tracker-labeled hCD34 ϩ cells were transplanted in Tg(fli1:EGFP) y1 embryos before the onset of gastrulation, at midblastula stage. The distribution of hCD34 ϩ cells in the developing embryos was analyzed immediately after injection and at tailbud and somite stages. Initially, cells remained mostly localized at the injection site at the embryo animal pole ( Figure 1A ). From tailbud stage to somite stage, a number of human cells were found in the midline, the head Figure  1A ). In situ hybridization using riboprobes to detect Scl and Gata2 mRNAs were then performed. The results revealed a strict association of human cells with multipotent Scl ϩ and Gata2 ϩ mesoderm cells ( Figure 1B ), suggesting cosegregation of human cells with zebrafish hemangioblasts. This behavior was specific; in fact, PB cells devoid of the CD14 ϩ monocyte cell population, having proangiogenic activity, 24 were not associated with Scl ϩ and Gata2 ϩ regions ( Figure 1C and Supplemental Figure I ).
Proliferation and survival of hCD34 ϩ cells transplanted into Tg(fli1:EGFP) y1 blastulas were evaluated at the 28 hpf stage by whole-mount staining for phosphohistone H3 and terminal deoxynucleotidyl transferase dUTP nick-end labeling. Both tests revealed little proliferation and only occasional apoptosis (Supplemental Figure II) . At this stage, human cells were found in primary and secondary blood vessels of the head, in the heart, in the dorsal aorta, in the posterior cardinal vein, in the caudal vein plexus, and in intersegmental and longitudinal vessels (Figure 2A to 2C). At the blastula stage, injection of CB-derived CD34 ϩ /CD45 Ϫ cells, considered to be containing putative ECFC progenitors, 10 produced analogous results (Supplemental Figure III) , whereas injection of melanoma cancer cells gave rise to formation of micrometastases in the head and the caudal vein plexus regions (Supplemental Figure IVA) . Finally, observation of transversal sections revealed the presence of hCD34 ϩ cells in the lumen, as well as in the wall of the dorsal aorta and in other vessels in strict association with EGFP ϩ host endothelial cells ( Figure 2D ).
To further investigate the phenotype of human cells, blastula-injected embryos were dissociated in single-cell suspensions at 28 and 48 hpf, followed by staining with antibodies recognizing human hematopoietic and endothelial markers and flow cytometry ( Figure 3 ). Human cells were easily recognized as a red-labeled population in dot plots representing red versus green fluorescence. In these cells ( Figure 3 and Supplemental Figures V and VI), CD3, CD4, CD8, and CD144 (VE-cadherin) were not expressed before or after injection; CD38, CD48, and CD105 exhibited a significant downregulation; endothelial marker CD146 was increased; and kinase insert domain receptor (KDR) was transiently upregulated at 28 hpf. Interestingly, the monocyte marker CD14 was expressed in a very small subset of hCD34 ϩ cells before injection, to be progressively upregulated at the 28 and 48 hpf stages; finally, endothelial marker CD31 and panhenatopoietic marker CD45 were expressed at high levels at all stages. To reveal coexpression of endothelial and hematopoietic markers in CD34 ϩ cells in the embryos, immunofluorescence in whole-mount embryos and on transversal frozen sections was performed. This revealed that vesselassociated human cells expressed the hemangioblast/endothelial marker KDR ( Figure 4A ) and the endothelial marker endothelin ( Figure 4B ). Strikingly, irrespective of their location in developing embryonic vessels, human-derived cells expressed the hematopoietic lineage marker CD45 ( Figure  4C ). Coexpression of CD45 with KDR was, finally, detected in vessel-associated human cells ( Figure 4D ).
Transition from endothelial to hematopoietic phenotype of cells localized in the wall of the dorsal aorta has been described as the major event associated with emergence of definitive HSCs in the zebrafish embryo. 13, 16 To assess whether EHT is affected by the presence of human cells, a 16-hour time-lapse video recording of Tg(KDRI:EGFP) S843 embryos injected at the blastula stage with CD34 ϩ cells was 
Postgastrula Stage Transplantation of hCD34 ؉ Cells Modulates Embryonic Vascular Development
The behavior of hCD34 ϩ cells injected into the circulatory system at the 48 hpf stage Tg(fli1:EGFP) y1 embryos was assessed by confocal time-lapse analysis. Early homing events in the blood vessels were observed as early as 30 minutes after injection (Supplemental Figure VIIA ). hCD34 ϩ cell rolling and adhesion to zebrafish intersegmental vessels were also observed (Supplemental Movie II).
Transgenic embryos injected with hCD34 ϩ cells at the 48 hpf stage were analyzed at the 72 hpf stage, ie, 24 hours after injection. Altered blood vessel sprouting in the growing tail vasculature (85% of 72 transplanted embryos; Supplemental Figure VIIIB 
Transplanted hCD34 ؉ Cells Rescue Defective Angiogenesis in the Zebrafish Embryo by Multifactorial Paracrine Effect
The previous data suggested that transplanted hCD34 ϩ cells have paracrine effects in the developing embryos. To assess this hypothesis, cells were injected at the blastula stage in Tg(fli1:EGFP) y1 embryos, where Vegf-c was knocked down by MO RNA injection at the 1-to 4-cell stage. As shown in Figure 5A , embryos depleted of Vegf-c exhibited defects in the development of the vascular system (30% of 50 MO RNA-injected embryos). Vegf-c depletion mostly affected the formation of the dorsal aorta, the posterior cardinal vein, the intersegmental vessels, and specific head arteries 25 (Figure 5B) . These defects were observed in only 9% (nϭ32) of Vegf-c-depleted/hCD34 ϩ cell-injected embryos ( Figure 5C ). Interestingly, phenotype rescue was complete even in vascular regions where CD34 ϩ cells failed to localize, suggesting complementation of Vegf-c knockdown defects by soluble factors secreted by human cells. Finally, hCD14 Ϫ cell injection in Vegf-c-depleted embryos did not rescue defective blood vessel formation (100% of vascular abnormalities, nϭ5 embryos injected with Vegf-c MO RNA and hCD14 Ϫ cells; data not shown). To identify paracrine factors participating in the rescue effect by injected cells, the secretion of interleukins, chemokines, and angiogenic growth factors was assessed by Luminex assay (Table) . The results showed production of several factors, including chemokines, proinflammatory, and proangiogenic cytokines, suggesting a potent paracrine effect by hCD34 ϩ cells. 
hCD34 ؉ Cells Accelerate Vascular Repair in Adult Zebrafish
The ability of hCD34 ϩ cells to enhance vascular repair in mammalian models of myocardial infarction and limb ischemia has been shown by us 26, 27 and by others. 28 -33 In the present study, we examined whether hCD34 ϩ cells contributed to vascular repair in adult zebrafish by injecting these cells in immunosuppressed Tg(fli1:EGFP) y1 adult animals after caudal fin amputation ( Figure 6A ), an established model of vascular regeneration in zebrafish. 34 -36 A significant increase in angiogenesis in hCD34 ϩ cell-transplanted versus vehicle-injected animals was found ( Figure 6B ).
Discussion
Bone marrow, PB, and CB contain EPCs that contribute to neovascularization in ischemic tissues. 1 EPCs have long been thought to derive from alternative differentiation pathways of hematopoietic progenitors because of the expression of markers (CD34, CD133, KDR) that they have in common with primitive HSCs. Embryology has suggested a different sce-nario. In fact, during vertebrate embryogenesis, HSCs derive from primitive cells located in a morphologically conserved region, called the aorta-gonad-mesonephros region, 37 whence definitive HSCs emerge by a novel modality of asymmetrical division of pluripotent nonhematopoietic cells, the so-called hemogenic endothelium. 13, 14 This division modality has been characterized in the zebrafish dorsal aorta and has been called EHT. 13 In the adulthood, the existence of 2 EPCs types, namely CFU-ECs (early EPCs) and ECFCs (late EPCs), 7 has been proposed. These cells likely have a different origin, although they are, at least in part, functionally overlapping. The most important proofs in favor of lineage separation between these 2 EPC types are (1) the expression of the panhematopietic marker CD45 in CFU-ECs but not in ECFCs, 4 and (2) the finding that ECFC clones from patients with myeloproliferative disorders do not harbor HSCs specific mutations, therefore identifying ECFCs as nonhematopoietic in origin. 7, 8, 10 According to this definition of EPCs, 5 progenitors obtained by bone marrow, PB, or CB cell sorting with CD34, CD133, and KDR markers without counterselection for CD45 should give rise only to CFU-ECs 38 and support neovascularization by paracrine interactions with resident endothelial cells. This latter hypothesis, however, is contradicted by several experimental findings showing that blood-borne stem cells give rise to endothelial cells in vitro and in ischemic tissues irrespective of their hematopoietic origin 2,3,26,29,33,39 -42 and by a very recent report showing that CD34 ϩ /CD38 ϩ /CD45 ϩ / CD133 ϩ CB progenitors differentiate in culture into clonally expanding endothelial cells, which, similarly to ECFCs, participate in neovascularization by incorporating into new blood vessels. 18
Transplantation of hCD34 ؉ Cells at Early Stages of Embryonic Zebrafish Development Unravels an Unexpected Hemangioblast-Like Behavior
Transplantation into midblastulas was performed to reveal the fate of hCD34 ϩ cells throughout the earliest stages of vascular development. These experiments showed that blastula-transplanted hCD34 ϩ cells were mostly cosegregated with the presumptive zebrafish Scl ϩ and Gata2 ϩ progenitors in the anterior and posterior lateral mesoderm. Thus, hCD34 ϩ cells migrated in concert with zebrafish mesoderm progenitors and colonized the anterior region, ie, the site where embryonic uncommitted progenitors are known to establish primitive hematopoiesis. 43 During somitogenesis, hCD34 ϩ cells migrated medially and posteriorly along the developing intermediate cell mass, to finally colonize the entire cardiovascular system at the 28 hpf stage. As shown by flow cytometry and immunofluorescence (Figures 3 and 4) , these morphogenetic events were associated with transient upregulation of KDR and overexpression of CD146 at all stages; importantly, this also coincided with downregulation of hematopoietic progenitor-specific markers CD38 and CD48. It was also remarkable that hCD34 ϩ cells showed increasing amounts of monocyte marker CD14 expression; that CD45 was not downregulated in KDR ϩ human cells (Figures 3 and  4) ; and that injection of hCD34 ϩ /CD45 Ϫ cells, the putative ECFC progenitors, 10 produced the same segregation pattern into various vascular districts (Supplemental Figure III) . Taken together, these results suggest that blastula-injected hCD34 ϩ cells were committed to multiple differentiation into Interestingly, a number of blastula-transplanted human cells were enclosed in the endothelial layer of the dorsal aorta at 28 hpf ( Figures 2D and 4) . This is consistent with the timing of EHT occurrence in the dorsal aorta of the developing zebrafish embryos. 13, 16 To check whether the presence of human cells alters the normal behavior of multipotent endothelial progenitors lining the dorsal aorta, we performed EHT imaging in KDR-EGFP embryos, which showed no abnormalities in the budding process of definitive HSCs (Supplemental Figure VII , Supplemental Movie I). The lack of substantial perturbation of the EHT process is an indication of a physiological integration of human cells into zebrafish developing vascular network, even if future work will be necessary to establish whether human cells actively participate in EHT in this system.
Paracrine Activity of hCD34 ؉ Cells in the Zebrafish Embryo
The angiogenic activity of human bone marrow-derived, 2 PB-derived, 44 or CB-derived 40 progenitors has been demonstrated in several studies based on injection of these cells in preclinical models of ischemic disease. Except for a few reports describing results of intravital microscopy analyses of stem cells homing to mouse vessels, 45 so far only indirect evidence of homing events in ischemic tissues, mostly based on tissue sectioning, has been provided. 26 The results of our hCD34 ϩ cell injection in postgastrulation-stage (48 hpf) embryos, showed that these cells circulated throughout the organism and produced early and late homing events, associated with abnormal or ectopic embryonic vasculature formation (Supplemental Figure VIII) . Interestingly, homing of hCD34 ϩ cells was observed in several districts of the vasculature; this was different from the behavior of the human PBderived CD14 Ϫ cells, which were used as a negative control (Supplemental Figure VIII) , or that of human melanoma and Hu indicates human; IL, interleukin; PDGF, platelet-derived growth factor; FGF, fibroblast growth factor; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor. CACO-2 stem cells, whose presence was mostly associated with the head; the caudal vein plexus, where they formed micrometastases; or the yolk region, where they caused ectopic vessel sprouting (Supplemental Figure IV) . 46 Direct participation in primary angiogenesis was not the only effect of hCD34 ϩ cell injection into developing zebrafish embryos. In fact, hCD34 ϩ cells rescued vascular defects caused by Vegf-c knockdown ( Figure 6 ), and when transplanted into immunosuppressed adults, they accelerated regeneration of the vascular network in the amputated caudal fins. This activity was due to secretion of several cytokines and chemokines implicated in (lympho)angiogenesis and inflammatory response (Supplemental Table I ). Taken together, and in line with the large existing literature on EPCs, these results suggest that transplanted hCD34 ϩ cells exert a potent paracrine effect 47 that rescues vascular developmental defects due to knockdown of Vegf-C, deregulates formation of normal vascular network in postgastrulation zebrafish embryos, and accelerates wound repair in adults.
Concluding Remarks
The identity of human-derived endothelial progenitors is a still open issue. Although the distinction between the 2 EPC types 10 has allowed reconciliation of the embryo with the adult stem cell worlds, it is still not clear whether, under pathological conditions or in developmental biology contexts, these cells may cross their lineage barriers and noncanonically differentiate into alternative or mixed phenotypes. Our findings suggest that this might be the case and call for further investigation aimed at clarifying the molecular nature of these possible events.
To our knowledge, the present study represents the first example of successful human stem cell transplantation into developing zebrafish embryos. In fact, apart from previous investigations showing the fate of human cancer cells in the developing zebrafish 48 and the recent demonstration of angiogenic activity of mouse and human tumor cell lines, 46 no other evidence exists that human stem cells colonize the developing zebrafish embryos and respond to specific developmental cues. In this context, our results may also have important translational implication for in utero correction of vascular defects in human embryos by injected stem cells.
It has been discussed that the developing zebrafish is an interesting microenvironment in which modulatory effects on the fate of injected cells are likely due to the presence of developmental mechanisms that are conserved among vertebrates. 48 In addition, given the relative ease of zebrafish genetic manipulation systems, xenotransplantation of human cells in zebrafish has been proposed as a reference technique to define the properties of human cancer (stem) cells. 49 Our study is in line with these emerging concepts and shows the versatility of this system to also address fundamental human developmental and cell biology questions.
